NAD+ Regulatory Status: Compounding and Access in 2026
A plain-language look at why a popular molecule sits in a regulatory gray zone.
TL;DR
NAD+ (nicotinamide adenine dinucleotide, a coenzyme your cells use for energy) is not an FDA-approved drug. Injectable and IV NAD+ reach patients through 503A compounding pharmacies. The FDA is still evaluating NAD for its bulk drug substances list, so access is real today but the rules are not fully settled.
NAD+ regulatory status: is NAD+ FDA approved
NAD+ is not FDA-approved as a medicine for wellness or anti-aging. No company has taken an injectable NAD+ product through the FDA's review for safety and effectiveness. What exists instead is compounded NAD+, prepared for individual prescriptions by licensed pharmacies. Compounded medications are not FDA-approved, which is an honest limit, not a loophole (FDA, Compounding Laws and Policies).
Why is NAD+ only available through compounding
NAD+ is available mainly through compounding because there is no approved brand-name version to buy. Think of it like a tailor-made suit versus one off the rack: when nothing off the rack exists, a licensed tailor makes it to order. A 503A pharmacy plays that role, preparing NAD+ from bulk ingredients when a clinician prescribes it. That is why you cannot pick it up like a standard prescription drug.
Is injectable NAD+ legal
Injectable NAD+ can be legally compounded and prescribed, but its footing is uncertain. Pharmacies may only compound from ingredients the FDA allows, tracked on the 503A bulk drug substances list. By 2016, NAD had been nominated for that 503A list, but the FDA has not finalized its status (FDA, Bulk Drug Substances Nominated for Compounding). In 2018, the first controlled human trial of an NAD precursor enrolled 24 adults and reported it was safe and well tolerated (Martens et al., Nature Communications, 2018). So the science and the rules are both still developing.
Who asks about it
People come to this topic after seeing NAD+ IV drips marketed for energy and aging, then wondering whether it is approved or even allowed. They want the honest regulatory picture before spending money.
The Halftime POV
We think NAD+ is a case study in reading the fine print. The molecule is interesting and the early research is worth watching, but "compounded" and "under FDA review" are facts a good clinic should state plainly. We would rather set that expectation up front than let a drip menu imply approval that does not exist.
Related reading:
FAQ
Is NAD+ FDA approved? No. There is no FDA-approved NAD+ drug for anti-aging or wellness use. Injectable and IV NAD+ are compounded by state-licensed 503A pharmacies from bulk ingredients. Compounded products are not FDA-approved, which means the FDA has not reviewed them for safety and effectiveness.
Why is NAD+ only available through compounding? NAD+ reaches patients through compounding because no manufacturer has taken an NAD+ injectable through the FDA approval process. Compounding pharmacies can prepare it for individual prescriptions, so access depends on a prescriber and a licensed pharmacy.
Is injectable NAD+ legal? Compounded injectable NAD+ can be prescribed and prepared by licensed 503A pharmacies, but its status is not settled. The FDA has been evaluating NAD for its 503A bulk drug substances list, and rules can change as that review proceeds.
What is the 503A bulk substances list? The 503A bulk drug substances list is the FDA's roster of raw ingredients that compounding pharmacies are cleared to use. NAD has been nominated and evaluated but not finalized, which is why its status carries uncertainty.
Disclaimer
This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.
Get updates
Sources
- U.S. Food and Drug Administration, Bulk Drug Substances Nominated for Use in Compounding: https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-nominated-use-compounding
- U.S. Food and Drug Administration, Compounding Laws and Policies: https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- Martens, C.R., et al. "Chronic nicotinamide riboside supplementation." Nature Communications, 2018: https://pubmed.ncbi.nlm.nih.gov/29514064/
Frequently asked questions
Is NAD+ FDA approved?
No. There is no FDA-approved NAD+ drug for anti-aging or wellness use. Injectable and IV NAD+ are compounded by state-licensed 503A pharmacies from bulk ingredients. Compounded products are not FDA-approved, which means the FDA has not reviewed them for safety and effectiveness.
Why is NAD+ only available through compounding?
NAD+ reaches patients through compounding because no manufacturer has taken an NAD+ injectable through the FDA approval process. Compounding pharmacies can prepare it for individual prescriptions. That is why access depends on a prescriber and a licensed pharmacy rather than a retail drug.
Is injectable NAD+ legal?
Compounded injectable NAD+ can be prescribed and prepared by licensed 503A pharmacies, but its status is not settled. The FDA has been evaluating NAD for its 503A bulk drug substances list, which governs what pharmacies may compound from. Rules can change as that review proceeds.
What is the 503A bulk substances list?
The 503A bulk drug substances list is the FDA's roster of raw ingredients that compounding pharmacies are cleared to use. Substances still under review sit in a gray zone. NAD has been nominated and evaluated but not finalized, which is why its status carries uncertainty.
Keep reading
A licensed physician can build a protocol from your own labs.
Membership from $69/mo, including your onboarding panel. Each protocol is its own monthly subscription.